Stay updated on Denosumab & Pembrolizumab in RCC Clinical Trial

Sign up to get notified when there's something new on the Denosumab & Pembrolizumab in RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Denosumab & Pembrolizumab in RCC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    No additions or deletions were detected. The page content and layout appear unchanged between the old and new versions.
    Difference
    0.4%
    Check dated 2025-11-03T12:44:07.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and a new version tag (v3.2.0), replacing the previous version (v3.1.0).
    Difference
    3%
    Check dated 2025-10-05T17:35:00.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Updated core term from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' and bumped revision from v3.0.2 to v3.1.0, indicating terminology refinement and a new version.
    Difference
    0.2%
    Check dated 2025-09-28T10:50:36.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed as a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-14T00:37:32.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.
    Difference
    0.2%
    Check dated 2025-09-06T21:32:28.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as specific medical terms related to clear cell renal carcinoma and various antibodies. Notably, previous terms related to antineoplastic agents and certain location details have been removed.
    Difference
    4%
    Check dated 2025-08-30T15:59:14.000Z thumbnail image

Stay in the know with updates to Denosumab & Pembrolizumab in RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Denosumab & Pembrolizumab in RCC Clinical Trial page.